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Abstract 
Background: The aim of the study was to perform qualitative and quantitative computed 
tomography (CT) angiography-based evaluation of patent ductus arteriosus (PDA) 
morphology and its influence on morphology of the great vessels.  
Materials and methods: Two-thousand twenty-two patients underwent 64-slice or dual-
source CT and were retrospectively screened for the presence of PDA. Those who had 
presence of PDA underwent evaluation of its anatomy and morphology.  
Results: Thirty-two adult patients with PDA were evaluated (mean age 41.4 ± 17.4 years). 
Subjects with PDA had a higher value of aortic isthmus (P=0.0148), main pulmonary artery 
(P<0.0001), right (P=0.0007) and left (P=0.0074) pulmonary arteries diameters than 
individuals from control group (16 adults, median age 43.3 ± 12.4 years). Types A, B, C, D, 
and E of PDA morphology occurred in 16 (50%), 3 (9%), 9 (28%), 2 (6%), and 2 patients 
(6%), respectively. Subjects with the type A configuration of PDA tended to have a larger 
diameter at the aortic orifice (10.2 ± 5.2mm vs 6.4 ± 4.9mm, p=0.09) and a larger maximal 
diameter (10.3 ± 5.3mm vs 7.1 ± 4.7mm, p=0.14) compared to subjects with the type C 
configuration. The values of minimal, mean, and maximal diameters of PDA were 4.7 ± 1.9 
mm, 7.0 ± 3.2 mm, and 9.4 ± 5.0 mm, respectively. The Spearman correlation coefficient 
between the main pulmonary artery (MPA) and PDA diameters demonstrated a good 
correlation for minimal (r=0.70, p<0.001), mean (r=0.62, p=001), and maximal (r=0.60, 
P=0.0003) PDA diameters.  
Conclusions: CT enables quantitative and qualitative evaluation of PDA, including its type of 
morphology, length, and diameters. In the evaluated adult population with PDA, the majority 
of patients had dilation of the aortic isthmus and pulmonary arteries. PDA diameters correlate 
with diameters of the pulmonary arteries and this correlation is strongest between PDA 
diameter at the narrowest site and main pulmonary artery. 





In fetal life, the arterial duct typically connects the descending thoracic aorta and the 
proximal left pulmonary artery, however, some variations in its origin and insertion may 
occur [1]. After birth, the arterial duct typically closes functionally within 24-48 hours and 
anatomically within 1 month [10]. Persistence of the arterial duct for more than 3 months after 
birth is a congenital heart defect known as patent ductus arteriosus (PDA), which occurs in 1 
out of 2000 full-term born children and comprises 5-10% of all congenital heart diseases 
[3,12]. Its clinical presentation may vary from completely asymptomatic to symptoms of 
congestive heart failure and is related to the magnitude of the shunt [14]. The value of the 
shunt depends on the length, diameter, and morphology of the PDA [10] and is also known to 
have an impact on morphology of the heart and great vessels [14]. The shunt is calculated as 
the ratio between flow through the pulmonary artery and the aorta [2,16]. According to the 
value of this ratio, the shunt may be classified as small (ratio <1.5), moderate (ratio 1.5-2.2) 
or large (ratio >2.2) [16]. Diagnostic imaging evaluation of the PDA may be performed either 
noninvasively by echocardiography, computed tomography (CT), and magnetic resonance or 
invasively by cardiac catheterization [10,14]. CT, unlike other methods, does not allow for 
flow quantification, however, it does enable a detailed evaluation of PDA morphology and 
size together with potential complications such as aneurysms, thrombi, and calcifications 
[1,10,14]. Such detailed evaluation is useful in the diagnosis of PDA and is crucial for the 
planning of PDA percutaneous closure [9]. Moreover, CT enables quantitative evaluation of 
great vessel morphometry including potential pulmonary artery hypertension and 
Eisenmenger syndrome [5]. To date, an angiographically based morphometric classification 
of the PDA by Krichenko et al. [11] has been utilized. However, it is limited since it is a 2-
dimensional image and has lower diagnostic accuracy in evaluation of thrombi and 
calcifications when compared to CT [11]. Magnetic resonance enables quantification of the 
shunt through the PDA, but its diagnostic value in PDA morphology evaluation is limited [2]. 
Qualitative and quantitative analysis of PDA morphometric details using CT is a new 
perspective which is lacking in previously published literature. Previous CT-based analyses 
[8,10] concentrated mostly on the detection and incidence of PDA in the population. 
Therefore, the aim of our study was to perform a CT angiography-based evaluation of PDA 
morphology and its influence on great vessel morphology. 
 
MATERIAL AND METHODS  
Two-thousand twenty-two patients underwent CT angiography of the thoracic aorta 
and were retrospectively screened for the presence of PDA. CT examinations were performed 
during a period of 10 consecutive years using 64-slice (Somatom Sensation 64 Cardiac, 
Siemens, Erlangen, Germany) or dual-source CT (Somatom Definition, Siemens, Erlangen, 
Germany). Patients underwent CT angiography due to known or suspected aortic disease 
including aortic aneurysm and congenital heart disease. Exclusion criteria for performing CT 
angiography were: pregnancy, known severe allergy to iodinated contrast, impaired renal 
function (serum creatinine ≥ 1.5 mg/dl), and thyroid disorders [13]. Contrast-enhanced 
acquisitions were performed during inspiratory breath hold with a collimation of 0.6mm. 
Field of view extended from the level above the aortic arch to the level below the diaphragm 
for the thoracic aorta. The bolus tracking method was used with the region of interest in the 
aortic arch and the scan was initiated when the density reached 180 Hounsfield Units. An 
iodinated contrast agent was injected at a rate of 5ml/s [13]. Images were reconstructed with 
an image matrix of 512 x 512 pixels. Post-processing and study evaluation were performed 
using a dedicated workstation (Syngovia, Siemens, Erlangen, Germany). Patients were 
assessed for the presence of PDA using axial, curved multiplanar, and volume-rendered 
technique reconstructions. In subjects with PDA, CT evaluation included quantitative and 
qualitative analysis of the aorta, PDA, and pulmonary arteries. Quantitative analysis included 
measurement of aortic, PDA, main pulmonary, and right and left pulmonary artery diameter 
(defined as the mean value of two perpendicular diameters) at the level of the ascending aorta 
at its maximal diameter, site of PDA, descending aorta at its maximal diameter, main 
pulmonary artery (MPA) at its maximal diameter, and right and left pulmonary arteries at 
their maximal diameters. Evaluation of PDAs included measurement of their length, diameter 
at their aortic and pulmonary endings (Figure 1) and in the middle part. Calculation of their 
minimal, maximal, and mean diameter was also performed. Qualitative analysis included 
evaluation for the presence of PDA thrombus, calcification [1,10,14], PDA morphometry [11] 
(Figure 2), aortic dilatation (defined as ≥ 37mm in the ascending, ≥30 mm in the isthmus and 
descending aorta) and dilatation of the pulmonary arteries (defined as ≥ 29mm in the MPA, 
≥20 mm in the left and right pulmonary arteries) [13]. 
Variables were presented as mean ± SD and compared to a randomly chosen control 
group using the Student’s t-test. Spearman correlation coefficient analyses were performed for 
comparison of measurements between PDA and pulmonary arteries. In qualitative analysis, 
the Chi-square test with Yates modification was used. P <0.05 was considered as statistically 
significant. The statistical analysis was performed using Statistica 10 software (StatSoft Inc.). 
The local bioethics committee approved the protocol and classified it as a retrospective study. 
 
RESULTS 
Thirty-two adult patients with PDA were evaluated (mean age 41.4 ± 17.4 years). 
Subjects with PDA had larger diameter of aortic isthmus (P = 0.0148), MPA (P < 0.0001), 
and right (P = 0.0007) and left (P = 0.0074) pulmonary arteries than individuals from the 
control group (16 adults, median age 43.3 ± 12.4 years). Sixteen (half of the evaluated 
population) randomly chosen patients were also evaluated as a control group. The detailed 
qualitative and quantitative analysis of aortic, main pulmonary, and right and left pulmonary 
arteries is presented in Table 1. PDA evaluation revealed the presence of calcifications and 
thrombi in 6 (19%) and 1 (3%) cases, respectively. The minimal, mean, and maximal 
diameters of PDA were 4.7 ±1.9 mm, 7.0 ±3.2 mm, and 9.4 ± 5.0 mm, respectively. Fourteen 
patients with age <40 years tended to have a lower minimal diameter of PDA than others (4.4 
±1.6 mm vs 4.9 ±2.2 mm, p=0.1). PDA Types A, B, C, D, and E, classified according to 
Krichenko et al. [11], were seen in 16 (50%), 3 (9%), 9 (28%), 2 (6%), and 2 patients (6%), 
respectively (Table 2).The Spearman correlation coefficient between MPA and PDA 
diameters demonstrated a good correlation for minimal (r=0.70, p<0.001), mean (r=0.62, 
p=001), and maximal (r=0.60, P=0,0003) PDA diameters. The Spearman correlation 
coefficient between right pulmonary artery (RPA) and PDA diameters demonstrated a fair 
correlation for minimal (r=0.57, p=0.007), mean (r=0.52, p=0.003), and maximal (r=0.49, 
p=0.004) PDA diameters. The Spearman correlation coefficient between left pulmonary artery 
(LPA) and PDA diameters demonstrated a fair correlation for minimal (r=0.46, p=0.008) and 
mean (r=0.40, p=0.02) PDA diameters while there was a poor correlation for maximal 
(r=0.39, p=0.03) PDA diameter. The Spearman correlation coefficient between aortic isthmus 
and PDA diameters demonstrated a fair correlation for minimal (r=0.46, p=0.009) and mean 
(r=0.41, p=0.08) PDA diameters while there was a poor correlation for maximal (r=0.27, 
p=0.14) PDA diameter. All evaluated PDAs were seen in a typical location and had a 
typically connected aortic isthmus and MPA-LPA connection site. . Subjects with the type A 
configuration of PDA tended to have a larger diameter at the aortic orifice (10.2±5.2mm vs 
6.4±4.9mm, p=0.09) and larger maximal diameter (10.3±5.3mm vs 7.1±4.7mm, p=0.14) when 
compared to subjects with the type C configuration. 
 
DISCUSSION 
The most common form of PDA is the Type A morphology of PDA and comprised 
half (50%) of the evaluated population. This observation is consistent with a study by 
Kirchenko et al. [11] which documented the occurrence of PDA with a wide aortic and 
narrow pulmonary orifice (type A) in the majority (64.5%) of patients with PDA. We found 
the type C (tubular with wide aortic and pulmonary orifices) morphology of PDA to be the 
second most frequent (28%), while in the previously mentioned study, the type B morphology 
of PDA (very short length, wide aortic and pulmonary orifices) was the second most frequent, 
with an occurrence of 17%. There are a few possible explanations for this discrepancy. 
Firstly, we evaluated adult patients (mean age 41.4 ± 17.4 years), while Krichenko et al. [11] 
evaluated a pediatric (mean age 6.2 ± 9.1 years) population. The distribution of PDA 
morphology may differ with age. Secondly, in our observation, the type B PDA tended to 
have a shorter length and higher value of minimal diameter than the type C PDA, which may 
result in a larger shunt [9], more severe clinical symptoms, and early PDA closure 
intervention in childhood. Thirdly, Krichenko et al. [11] used the narrowest site of PDA as the 
landmark while we performed 3-dimensional CT-based evaluation. This led to a more detailed 
morphometric qualitative and quantitative analysis, not only based on the measurement at the 
site of maximal narrowing, but also sites of aortic and pulmonary orifices and PDA length. In 
our quantitative analysis, subjects with the type A configuration of PDA compared to subjects 
with the type C configuration tended to have a larger diameter at the aortic orifice and larger 
maximal diameter. Quantitative evaluation confirmed previous qualitative findings of larger 
aortic than pulmonary orifices in patients with the type A morphology of PDA (10.2 ±5.2 mm 
vs 5.1 ±2.7 mm, p=0.0001). These observations are consistent with qualitative evaluation by 
Krichenko et al. [11]. In both studies, types D (with multiple constrictions) and E (elongated 
with distal constriction) ducts were marginal and made up only a few percent of patients. Our 
qualitative CT analysis enabled detection of PDA thrombi and calcifications, which is 
essential in the planning of PDA percutaneous closure [12]. Comparison with previous studies 
regarding prevalence of PDA thrombus and calcification is limited due to the use of invasive 
angiography and a lack of specific data. [1,10,14].  
Interestingly, in our study the mean value of narrowest PDA diameter was higher than 
in the above cited study (4.8 ±1.9 mm vs 3.2 ±1.0 mm, p<0.0001). This could be due to a 
more accurate 2-dimensional measurement of the site (of maximal narrowing) using CT than 
the 1-dimensional measurement from invasive catheter angiography. Another reason for this 
discrepancy may be the different ages in the two evaluated populations. The minimal PDA 
diameter might have increased with age, and this theory supports our finding which is a 
tendency toward lower minimal PDA diameter in patients younger than 40 years of age when 
compared to others. Moreover, a minimal diameter <3mm favors intravascular occlusion [18], 
which might have occurred in childhood and excluded such patients from our population. 
Patients with PDA had a larger diameter and dilatation of aortic isthmus and 
pulmonary arteries than individuals from the control group, however, no dilatation of the 
ascending and descending aorta was observed. Lack of ascending aortic dilatation is contrary 
to previous analyses [5,10,11], while dilatation of aortic isthmus and pulmonary arteries is 
consistent with the above-mentioned publications. PDA diameters demonstrated the strongest 
correlation with MPA diameters and a decrease in its value was observed when compared 
with LPA, RPA, and aortic isthmus. This may result from the fact that all PDAs had a typical 
location and a typically connected aortic isthmus and site of MPA-LPA junction. 
Interestingly, aortic isthmus and pulmonary artery diameters had the strongest correlation 
with minimal PDA diameters and weakest correlation with maximal PDA diameters. This 
suggests that the degree of shunting through a PDA is limited by its narrowest, not its widest 
site, and that its significance influences dilatation of aortic isthmus and pulmonary arteries. To 
the best of our knowledge, this is the first such observation, which was enabled by 
quantitative CT evaluation.  
The presence of clinical symptoms in patients with PDA is related to the magnitude of 
the shunt through the duct [14]. It was observed that patients with short and wide PDAs are 
more symptomatic than others [10]. Study by Evans et al. [6] classified ducts with diameter 
>1.5 mm as hemodynamically significant, but it cannot be compared to our analysis as it was 
performed basing on echocardiographic evaluation in preterm infants. In our study performed 
in an adult population the mean value of the minimal diameter was more than three times 
greater and revealed 4.7 ±1.9 mm. Other quantitative echocardiographic markers suggesting 
hemodynamically significant shunt in preterm infants are diastolic flow velocity in the left 
pulmonary artery (LPA) >0.2 m/s [17], increased left ventricular output (LVO) [19] and 
increased peripheral vascular resistance index [15]. However, all above listed studies were 
different from our analysis which is morphological CT based evaluation of PDA in an adult 
population. In premature infants significant shunt through PDA results in pulmonary 
hyperperfusion and peripheral hypoperfusion, which cause potentially fatal complications 
such as intraventricular haemorrhage, necrotising enterocolitis, kidney injury, heart failure, 
and chronic lung disease [4]. In an adult population clinical presentation of PDA may be 
completely asymptomatic in a small duct [7], while in a moderate to large duct the symptoms 
include tachycardia, exertional dyspnea and hoarseness in presence of a very large duct [7, 
14]. Those symptoms occur due to development of congestive heart failure with pulmonary 
overcirculation and left heart volume overload. In clinical examination moderate to large 
ducts commonly reveal continuous heart murmur with concomitant hyperactive precordium 
and bounding peripheral pulses, while small ducts usually remain silent without presence of 
murmur [7]. To our best knowledge no evaluation of duct location and size measurements 
related to occurrence of clinical symptoms in an adult population was so far performed and is 
an interesting perspective missing in the existing literature. That is why lack of collection of 
clinical symptoms, diagnostics with evaluation of the magnitude of a shunt and follow up in 
the evaluated population is a major limitation of our study. 
Unfortunately, the small patient population included in our study limits the statistical 
significance of the entire analysis. The study by Krichenko et al. [11] involved a larger patient 
population, however, they did not evaluate vessels other than PDA, which was done in our 
study. Finally, studies of PDA can be performed without ionizing radiation using magnetic 
resonance or echocardiography [16].  
 
CONCLUSIONS 
CT enables quantitative and qualitative evaluation of PDA, including its type of 
morphology, length, and diameter. In the evaluated adult population with PDA, the majority 
of patients had dilatation of aortic isthmus and pulmonary arteries. PDA diameters correlated 
with pulmonary artery diameters and this correlation was strongest between PDA diameter at 
the narrowest site and main pulmonary artery. 
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Table 1. The results of quantitative and qualitative computed tomography analysis of aorta 
and pulmonary arteries in patients with PDA compared with control group. 
Variable Patients with 
PDA (n=32) 
Mean ± SD 
Control group 
(n=16)  
Mean ± SD 
P 
Ascending aorta diameter 
(mm) 
33.4 ± 7.3 32.4 ± 4.6 P = 0,6554  
Ascending aorta 
dilatation 
9 3 P=0,72522 
Aortic isthmus diameter 
(mm) 
28.8 ± 6.3 24.5 ± 3.5 P = 0,0148 
Aortic isthmus dilatation 17 3 P = 0,031240   
Descending aorta 
diameter (mm) 
24.6 ± 2.8 22.7 ± 3.8 P = 0,0833 
Descending aorta 
dilatation 
1 1 P=1 
MPA diameter (mm)  34.0 ± 6.5 21.7 ± 3.7 P < 0,0001 
MPA dilatation 27 1 P < 0,0001 
RPA diameter (mm) 24.3 ± 5.4 
 
 
19.2 ± 2.1 P = 0,0007 
RPA dilatation 26 6 P = 0,007660 
LPA diameter (mm) 22.4 ± 3.9 19.6 ± 1.1 P = 0,0074 
LPA dilatation 26 8 P = 0,042101   
  






















4.8±2.2 5.8±2.3 4.3±2.0 3.8±0.4 4.7±0.4 
Maximal diameter 
(mm) 
10.3±5.3 13±4.2 7.1±4.7 9.0±5.7 7.8±1.4 
Mean diameter 
(mm) 
7.4±3.0 9.8±3.8 5.8±3.5 5.8±2.6 5.8±0.2 
Aortic orifice 
diameter (mm) 
10.2±5.2 12.2±10.2 6.4±4.9 5.2±5.8 4.5 ± 0.4 
Pulmonary orifice 
diameter (mm) 
5.1±2.7 8.7 ±7.8 5.5 ± 4.2 3.8 ± 0.4 3.3±4.0 
PDA length (mm) 7.5± 3.0 3.0 ± 1 5.4±1.5 17±4.2 14.5±0.7 
Figure 1. Multiplanar (A, B, C) and volume rendered technique reconstructions (VRT) (D) of 
patent ductus arteriosus (PDA). Quantitative evaluation of length (A), aortic and pulmonary 
orifices (B, C). 
Figure 2. Multiplanar and volume rendered technique (VRT) reconstructions of patent ductus 
arteriosus (PDA) morphology types: A) “conical” with wide aortic and narrower pulmonary 
orifices; B) “window” with very short length, wide aortic and pulmonary orifices; C) 
“tubular” with wide aortic and pulmonary orifices; D) “complex” with multiple constrictions; 
E) “elongated” with distal constriction. 
Figure 3. Variations in PDA configuration illustrated with the classification of Krichenko et 
al.: A, Type A: conical ductus with prominent aortic ampulla and constriction near the 
pulmonary artery end. B, Type B: window-like (wide and very short) ductus. C, Type C: 
tubular ductus without constrictions. D, Type D: complex ductus with multiple constrictions. 
E, Type E: elongated ductus with constriction remote from the anterior edge of the trachea 
(when viewed on lateral angiography). Source: https://radiopaedia.org/cases/krichenko-
angiographic-classification-of-patent-ductus-arteriosus-illustration.CC licence, BY, NC, ND.  
 



